Barclays
DRTS icon

Barclays’s Alpha Tau Medical DRTS Stock Holding History

Barclays’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Buy
+233
New +$2.12K ﹤0.01% 4832
2022
Q3 		– Sell
-16,000
Closed -$144K – 4872
2022
Q2 		$144K Sell
16,000
-61,756
-79% -$553K ﹤0.01% 3594
2022
Q1 		$918K Buy
+77,756
New +$914K ﹤0.01% 2482

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Barclays's DRTS Position: Q2 2026 in Review

Barclays opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 233 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #4832 among its holdings. This is a return to the name: Barclays previously reported a position in DRTS as recently as Q2 2022.

Barclays first reported a position in DRTS in Q1 2022 and has held it in 3 quarters since. The position peaked at $918K in Q1 2022. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Barclays held 233 shares of Alpha Tau Medical worth $2.93K as of Q2 2026.
  • Alpha Tau Medical was a new Barclays position in Q2 2026.
  • Alpha Tau Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4832 holding.
  • Barclays first reported a position in Alpha Tau Medical in Q1 2022 and has held it in 3 quarters since.
  • Barclays's Alpha Tau Medical position peaked at $918K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.